nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Prostaglandins—Latanoprost—glaucoma	0.14	0.5	CiPCiCtD
Bimatoprost—Prostaglandins—Travoprost—glaucoma	0.14	0.5	CiPCiCtD
Bimatoprost—PTGFR—glaucoma	0.134	1	CbGaD
Bimatoprost—Travoprost—glaucoma	0.117	0.518	CrCtD
Bimatoprost—Latanoprost—glaucoma	0.109	0.482	CrCtD
Bimatoprost—PTGFR—Travoprost—glaucoma	0.0851	0.608	CbGbCtD
Bimatoprost—PTGFR—Latanoprost—glaucoma	0.0548	0.392	CbGbCtD
Bimatoprost—Iloprost—Latanoprost—glaucoma	0.0285	0.195	CrCrCtD
Bimatoprost—Carboprost Tromethamine—Travoprost—glaucoma	0.0204	0.139	CrCrCtD
Bimatoprost—Travoprost—Latanoprost—glaucoma	0.0189	0.129	CrCrCtD
Bimatoprost—Latanoprost—Travoprost—glaucoma	0.0176	0.12	CrCrCtD
Bimatoprost—Tafluprost—Travoprost—glaucoma	0.0176	0.12	CrCrCtD
Bimatoprost—Tafluprost—Latanoprost—glaucoma	0.0164	0.112	CrCrCtD
Bimatoprost—Dinoprost Tromethamine—Travoprost—glaucoma	0.014	0.0956	CrCrCtD
Bimatoprost—Dinoprost Tromethamine—Latanoprost—glaucoma	0.013	0.0889	CrCrCtD
Bimatoprost—PTGFR—ciliary body—glaucoma	0.00765	0.893	CbGeAlD
Bimatoprost—PTGER3—Prostanoid ligand receptors—PTGFR—glaucoma	0.00153	0.0967	CbGpPWpGaD
Bimatoprost—PTGER1—Prostanoid ligand receptors—PTGFR—glaucoma	0.00112	0.0708	CbGpPWpGaD
Bimatoprost—PTGER3—Eicosanoid ligand-binding receptors—PTGFR—glaucoma	0.00102	0.0643	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000857	0.0541	CbGpPWpGaD
Bimatoprost—PTGER3—Small Ligand GPCRs—PTGFR—glaucoma	0.000843	0.0532	CbGpPWpGaD
Bimatoprost—PTGER1—Eicosanoid ligand-binding receptors—PTGFR—glaucoma	0.000745	0.047	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000641	0.0405	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000627	0.0396	CbGpPWpGaD
Bimatoprost—PTGER1—Small Ligand GPCRs—PTGFR—glaucoma	0.000617	0.0389	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000585	0.0369	CbGpPWpGaD
Bimatoprost—AKR1C3—Retinoid metabolism and transport—LRP12—glaucoma	0.000516	0.0325	CbGpPWpGaD
Bimatoprost—PTGER3—connective tissue—glaucoma	0.000501	0.0585	CbGeAlD
Bimatoprost—AKR1C3—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000445	0.0281	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000428	0.027	CbGpPWpGaD
Bimatoprost—PTGFR—eye—glaucoma	0.000416	0.0485	CbGeAlD
Bimatoprost—Travoprost—PTGFR—glaucoma	0.000384	0.275	CrCbGaD
Bimatoprost—Carboprost Tromethamine—PTGFR—glaucoma	0.000291	0.208	CrCbGaD
Bimatoprost—Tafluprost—PTGFR—glaucoma	0.000271	0.194	CrCbGaD
Bimatoprost—AKR1C3—Diseases associated with visual transduction—LRP12—glaucoma	0.000263	0.0166	CbGpPWpGaD
Bimatoprost—Latanoprost—PTGFR—glaucoma	0.00023	0.165	CrCbGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000194	0.0123	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000145	0.00918	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000142	0.00898	CbGpPWpGaD
Bimatoprost—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000141	0.00889	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000127	0.00802	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000116	0.00733	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000113	0.00712	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—OPN4—glaucoma	0.000112	0.00709	CbGpPWpGaD
Bimatoprost—Dinoprost Tromethamine—PTGFR—glaucoma	0.000111	0.0793	CrCbGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—OPN4—glaucoma	0.00011	0.00694	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000108	0.00684	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000105	0.0066	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000101	0.00634	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	9.95e-05	0.00628	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—PTGFR—glaucoma	9.9e-05	0.00625	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	9.84e-05	0.00621	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	9.5e-05	0.00599	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	9.3e-05	0.00587	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—SMO—glaucoma	9.08e-05	0.00573	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	8.96e-05	0.00566	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	8.86e-05	0.00559	CbGpPWpGaD
Bimatoprost—AKR1C3—Retinoid metabolism and transport—APOE—glaucoma	8.7e-05	0.00549	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	8.69e-05	0.00548	CbGpPWpGaD
Bimatoprost—Dinoprostone—PTGFR—glaucoma	8.52e-05	0.061	CrCbGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	8.5e-05	0.00537	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	8.1e-05	0.00511	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	7.93e-05	0.00501	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	7.66e-05	0.00483	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—OPN4—glaucoma	7.58e-05	0.00478	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	7.44e-05	0.0047	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	7.29e-05	0.0046	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—PTGFR—glaucoma	6.82e-05	0.00431	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	6.56e-05	0.00414	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—OPN4—glaucoma	5.67e-05	0.00358	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—OPN4—glaucoma	5.55e-05	0.0035	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PTGS2—glaucoma	5.09e-05	0.00321	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—PTGFR—glaucoma	4.99e-05	0.00315	CbGpPWpGaD
Bimatoprost—AKR1C3—Diseases associated with visual transduction—APOE—glaucoma	4.44e-05	0.0028	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—OPN4—glaucoma	4.28e-05	0.0027	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—CYP1B1—glaucoma	4.14e-05	0.00261	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.92e-05	0.00248	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—OPN4—glaucoma	3.89e-05	0.00245	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PTGFR—glaucoma	3.86e-05	0.00243	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CA5A—glaucoma	3.69e-05	0.00233	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NARFL—glaucoma	3.69e-05	0.00233	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PTGFR—glaucoma	3.5e-05	0.00221	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—SMO—glaucoma	3.44e-05	0.00217	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—EDN1—glaucoma	3.36e-05	0.00212	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—LRP12—glaucoma	3.34e-05	0.00211	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LRP12—glaucoma	3.31e-05	0.00209	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—GSTM1—glaucoma	3.31e-05	0.00209	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—EDN1—glaucoma	3.29e-05	0.00208	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—C3—glaucoma	3.27e-05	0.00207	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—OPN4—glaucoma	3.2e-05	0.00202	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—OPN4—glaucoma	3.14e-05	0.00198	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.01e-05	0.0019	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.98e-05	0.00188	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.94e-05	0.00186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—OPN4—glaucoma	2.91e-05	0.00184	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—OPN4—glaucoma	2.85e-05	0.0018	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PTGFR—glaucoma	2.82e-05	0.00178	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.6e-05	0.00164	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—SMO—glaucoma	2.57e-05	0.00162	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PTGFR—glaucoma	2.56e-05	0.00162	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—SMO—glaucoma	2.52e-05	0.00159	CbGpPWpGaD
Bimatoprost—Tafluprost—PTGS2—glaucoma	2.49e-05	0.0178	CrCbGaD
Bimatoprost—PTGFR—Signaling Pathways—LRP12—glaucoma	2.48e-05	0.00156	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LRP12—glaucoma	2.43e-05	0.00153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LRP12—glaucoma	2.34e-05	0.00148	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—OPN4—glaucoma	2.3e-05	0.00145	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—EDN1—glaucoma	2.27e-05	0.00143	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.23e-05	0.00141	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.18e-05	0.00138	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGFR1OP—glaucoma	2.15e-05	0.00136	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HEYL—glaucoma	2.15e-05	0.00136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HEYL—glaucoma	2.14e-05	0.00135	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTGFR—glaucoma	2.07e-05	0.00131	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—C3—glaucoma	1.98e-05	0.00125	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.95e-05	0.00123	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.9e-05	0.0012	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CA1—glaucoma	1.8e-05	0.00114	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—SMO—glaucoma	1.77e-05	0.00111	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CTSA—glaucoma	1.75e-05	0.0011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—OPN4—glaucoma	1.72e-05	0.00108	CbGpPWpGaD
Bimatoprost—Dizziness—Carbachol—glaucoma	1.7e-05	0.000362	CcSEcCtD
Bimatoprost—Insomnia—Apraclonidine—glaucoma	1.7e-05	0.000361	CcSEcCtD
Bimatoprost—Vertigo—Dorzolamide—glaucoma	1.7e-05	0.00036	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—EDN1—glaucoma	1.7e-05	0.00107	CbGpPWpGaD
Bimatoprost—Vertigo—Travoprost—glaucoma	1.69e-05	0.000359	CcSEcCtD
Bimatoprost—Chest pain—Brimonidine—glaucoma	1.68e-05	0.000358	CcSEcCtD
Bimatoprost—Diplopia—Timolol—glaucoma	1.68e-05	0.000357	CcSEcCtD
Bimatoprost—Vision blurred—Pilocarpine—glaucoma	1.68e-05	0.000357	CcSEcCtD
Bimatoprost—Headache—Carteolol—glaucoma	1.68e-05	0.000357	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—OPN4—glaucoma	1.68e-05	0.00106	CbGpPWpGaD
Bimatoprost—Anxiety—Brimonidine—glaucoma	1.68e-05	0.000356	CcSEcCtD
Bimatoprost—Dizziness—Levobunolol—glaucoma	1.68e-05	0.000356	CcSEcCtD
Bimatoprost—Dyspnoea—Apraclonidine—glaucoma	1.68e-05	0.000356	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	1.67e-05	0.000355	CcSEcCtD
Bimatoprost—Somnolence—Apraclonidine—glaucoma	1.67e-05	0.000355	CcSEcCtD
Bimatoprost—Palpitations—Dorzolamide—glaucoma	1.67e-05	0.000354	CcSEcCtD
Bimatoprost—Vertigo—Brinzolamide—glaucoma	1.67e-05	0.000354	CcSEcCtD
Bimatoprost—Pruritus—Latanoprost—glaucoma	1.66e-05	0.000353	CcSEcCtD
Bimatoprost—Rash—Diclofenamide—glaucoma	1.66e-05	0.000353	CcSEcCtD
Bimatoprost—Palpitations—Travoprost—glaucoma	1.66e-05	0.000353	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—EDN1—glaucoma	1.66e-05	0.00105	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Betaxolol—glaucoma	1.66e-05	0.000351	CcSEcCtD
Bimatoprost—Headache—Diclofenamide—glaucoma	1.65e-05	0.000351	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CA2—glaucoma	1.65e-05	0.00104	CbGpPWpGaD
Bimatoprost—Cough—Dorzolamide—glaucoma	1.65e-05	0.00035	CcSEcCtD
Bimatoprost—Dry mouth—Brimonidine—glaucoma	1.65e-05	0.00035	CcSEcCtD
Bimatoprost—Rhinitis—Clonidine—glaucoma	1.64e-05	0.000349	CcSEcCtD
Bimatoprost—Cough—Travoprost—glaucoma	1.64e-05	0.000348	CcSEcCtD
Bimatoprost—Palpitations—Brinzolamide—glaucoma	1.64e-05	0.000348	CcSEcCtD
Bimatoprost—Hypertension—Dorzolamide—glaucoma	1.63e-05	0.000346	CcSEcCtD
Bimatoprost—Rash—Carbachol—glaucoma	1.62e-05	0.000345	CcSEcCtD
Bimatoprost—Hypertension—Travoprost—glaucoma	1.62e-05	0.000345	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Apraclonidine—glaucoma	1.62e-05	0.000345	CcSEcCtD
Bimatoprost—Dermatitis—Carbachol—glaucoma	1.62e-05	0.000344	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—OPN4—glaucoma	1.62e-05	0.00102	CbGpPWpGaD
Bimatoprost—Cough—Brinzolamide—glaucoma	1.62e-05	0.000344	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—RPTOR—glaucoma	1.62e-05	0.00102	CbGpPWpGaD
Bimatoprost—Headache—Carbachol—glaucoma	1.61e-05	0.000343	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.61e-05	0.00102	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.61e-05	0.00102	CbGpPWpGaD
Bimatoprost—Chest pain—Dorzolamide—glaucoma	1.61e-05	0.000341	CcSEcCtD
Bimatoprost—Pain—Apraclonidine—glaucoma	1.61e-05	0.000341	CcSEcCtD
Bimatoprost—Infection—Brimonidine—glaucoma	1.6e-05	0.00034	CcSEcCtD
Bimatoprost—Hypertension—Brinzolamide—glaucoma	1.6e-05	0.00034	CcSEcCtD
Bimatoprost—Anxiety—Dorzolamide—glaucoma	1.6e-05	0.00034	CcSEcCtD
Bimatoprost—Chest pain—Travoprost—glaucoma	1.6e-05	0.00034	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—HEYL—glaucoma	1.6e-05	0.00101	CbGpPWpGaD
Bimatoprost—Anxiety—Travoprost—glaucoma	1.6e-05	0.000339	CcSEcCtD
Bimatoprost—Nausea—Carteolol—glaucoma	1.6e-05	0.000338	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	1.59e-05	0.000338	CcSEcCtD
Bimatoprost—Headache—Levobunolol—glaucoma	1.59e-05	0.000337	CcSEcCtD
Bimatoprost—Depression—Betaxolol—glaucoma	1.58e-05	0.000336	CcSEcCtD
Bimatoprost—Nervous system disorder—Brimonidine—glaucoma	1.58e-05	0.000336	CcSEcCtD
Bimatoprost—Chest pain—Brinzolamide—glaucoma	1.58e-05	0.000336	CcSEcCtD
Bimatoprost—Palpitations—Pilocarpine—glaucoma	1.58e-05	0.000335	CcSEcCtD
Bimatoprost—Dry mouth—Dorzolamide—glaucoma	1.57e-05	0.000334	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	1.57e-05	0.000333	CcSEcCtD
Bimatoprost—Skin disorder—Brimonidine—glaucoma	1.57e-05	0.000333	CcSEcCtD
Bimatoprost—Nausea—Diclofenamide—glaucoma	1.57e-05	0.000333	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NCK2—glaucoma	1.57e-05	0.000989	CbGpPWpGaD
Bimatoprost—Dry mouth—Travoprost—glaucoma	1.57e-05	0.000332	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—HEYL—glaucoma	1.56e-05	0.000987	CbGpPWpGaD
Bimatoprost—Cough—Pilocarpine—glaucoma	1.56e-05	0.000331	CcSEcCtD
Bimatoprost—Dizziness—Latanoprost—glaucoma	1.56e-05	0.00033	CcSEcCtD
Bimatoprost—Liver function test abnormal—Timolol—glaucoma	1.55e-05	0.00033	CcSEcCtD
Bimatoprost—Dry mouth—Brinzolamide—glaucoma	1.55e-05	0.000328	CcSEcCtD
Bimatoprost—Hypertension—Pilocarpine—glaucoma	1.54e-05	0.000327	CcSEcCtD
Bimatoprost—Rash—Methazolamide—glaucoma	1.53e-05	0.000325	CcSEcCtD
Bimatoprost—Dermatitis—Methazolamide—glaucoma	1.53e-05	0.000325	CcSEcCtD
Bimatoprost—Eye disorder—Clonidine—glaucoma	1.53e-05	0.000325	CcSEcCtD
Bimatoprost—Nausea—Carbachol—glaucoma	1.53e-05	0.000325	CcSEcCtD
Bimatoprost—Infection—Travoprost—glaucoma	1.53e-05	0.000324	CcSEcCtD
Bimatoprost—Headache—Methazolamide—glaucoma	1.52e-05	0.000323	CcSEcCtD
Bimatoprost—Chest pain—Pilocarpine—glaucoma	1.52e-05	0.000323	CcSEcCtD
Bimatoprost—Anxiety—Pilocarpine—glaucoma	1.51e-05	0.000322	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—PTGFR—glaucoma	1.51e-05	0.000956	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HEYL—glaucoma	1.51e-05	0.000952	CbGpPWpGaD
Bimatoprost—Nausea—Levobunolol—glaucoma	1.51e-05	0.00032	CcSEcCtD
Bimatoprost—Infection—Brinzolamide—glaucoma	1.51e-05	0.00032	CcSEcCtD
Bimatoprost—Nervous system disorder—Travoprost—glaucoma	1.51e-05	0.00032	CcSEcCtD
Bimatoprost—Nasopharyngitis—Timolol—glaucoma	1.51e-05	0.00032	CcSEcCtD
Bimatoprost—Somnolence—Acetazolamide—glaucoma	1.5e-05	0.000317	CcSEcCtD
Bimatoprost—Skin disorder—Travoprost—glaucoma	1.49e-05	0.000317	CcSEcCtD
Bimatoprost—Sinusitis—Betaxolol—glaucoma	1.49e-05	0.000316	CcSEcCtD
Bimatoprost—Nervous system disorder—Brinzolamide—glaucoma	1.49e-05	0.000316	CcSEcCtD
Bimatoprost—Angiopathy—Clonidine—glaucoma	1.49e-05	0.000315	CcSEcCtD
Bimatoprost—Rash—Latanoprost—glaucoma	1.48e-05	0.000315	CcSEcCtD
Bimatoprost—Dermatitis—Latanoprost—glaucoma	1.48e-05	0.000315	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—C3—glaucoma	1.48e-05	0.000935	CbGpPWpGaD
Bimatoprost—Dyspepsia—Acetazolamide—glaucoma	1.48e-05	0.000314	CcSEcCtD
Bimatoprost—Mediastinal disorder—Clonidine—glaucoma	1.48e-05	0.000313	CcSEcCtD
Bimatoprost—Headache—Latanoprost—glaucoma	1.47e-05	0.000313	CcSEcCtD
Bimatoprost—Skin disorder—Brinzolamide—glaucoma	1.47e-05	0.000313	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—PTGFR—glaucoma	1.46e-05	0.000922	CbGpPWpGaD
Bimatoprost—Insomnia—Brimonidine—glaucoma	1.46e-05	0.00031	CcSEcCtD
Bimatoprost—Asthma—Timolol—glaucoma	1.46e-05	0.000309	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Acetazolamide—glaucoma	1.45e-05	0.000308	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—C3—glaucoma	1.45e-05	0.000915	CbGpPWpGaD
Bimatoprost—Infection—Pilocarpine—glaucoma	1.45e-05	0.000307	CcSEcCtD
Bimatoprost—Nausea—Methazolamide—glaucoma	1.44e-05	0.000306	CcSEcCtD
Bimatoprost—Dyspnoea—Brimonidine—glaucoma	1.44e-05	0.000306	CcSEcCtD
Bimatoprost—Somnolence—Brimonidine—glaucoma	1.44e-05	0.000305	CcSEcCtD
Bimatoprost—Rhinitis—Betaxolol—glaucoma	1.43e-05	0.000303	CcSEcCtD
Bimatoprost—Erythema—Clonidine—glaucoma	1.43e-05	0.000303	CcSEcCtD
Bimatoprost—Dyspepsia—Brimonidine—glaucoma	1.42e-05	0.000302	CcSEcCtD
Bimatoprost—Pharyngitis—Betaxolol—glaucoma	1.42e-05	0.0003	CcSEcCtD
Bimatoprost—Tension—Clonidine—glaucoma	1.4e-05	0.000297	CcSEcCtD
Bimatoprost—Insomnia—Dorzolamide—glaucoma	1.39e-05	0.000296	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Brimonidine—glaucoma	1.39e-05	0.000296	CcSEcCtD
Bimatoprost—Nervousness—Clonidine—glaucoma	1.38e-05	0.000294	CcSEcCtD
Bimatoprost—Pain—Brimonidine—glaucoma	1.38e-05	0.000293	CcSEcCtD
Bimatoprost—Dyspnoea—Dorzolamide—glaucoma	1.38e-05	0.000292	CcSEcCtD
Bimatoprost—Visual impairment—Betaxolol—glaucoma	1.37e-05	0.000292	CcSEcCtD
Bimatoprost—Insomnia—Brinzolamide—glaucoma	1.37e-05	0.000291	CcSEcCtD
Bimatoprost—Somnolence—Dorzolamide—glaucoma	1.37e-05	0.000291	CcSEcCtD
Bimatoprost—Dyspnoea—Travoprost—glaucoma	1.37e-05	0.000291	CcSEcCtD
Bimatoprost—Dyspepsia—Dorzolamide—glaucoma	1.36e-05	0.000288	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Timolol—glaucoma	1.35e-05	0.000287	CcSEcCtD
Bimatoprost—Dyspnoea—Brinzolamide—glaucoma	1.35e-05	0.000287	CcSEcCtD
Bimatoprost—Dyspepsia—Travoprost—glaucoma	1.35e-05	0.000287	CcSEcCtD
Bimatoprost—Asthenia—Apraclonidine—glaucoma	1.35e-05	0.000286	CcSEcCtD
Bimatoprost—Somnolence—Brinzolamide—glaucoma	1.35e-05	0.000286	CcSEcCtD
Bimatoprost—AKR1C3—Disease—HDAC9—glaucoma	1.34e-05	0.000848	CbGpPWpGaD
Bimatoprost—Vision blurred—Clonidine—glaucoma	1.34e-05	0.000285	CcSEcCtD
Bimatoprost—Dyspepsia—Brinzolamide—glaucoma	1.33e-05	0.000283	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—HDAC9—glaucoma	1.33e-05	0.000841	CbGpPWpGaD
Bimatoprost—Eye disorder—Betaxolol—glaucoma	1.33e-05	0.000283	CcSEcCtD
Bimatoprost—Pruritus—Apraclonidine—glaucoma	1.33e-05	0.000282	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Travoprost—glaucoma	1.33e-05	0.000281	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—SMO—glaucoma	1.32e-05	0.000833	CbGpPWpGaD
Bimatoprost—Pain—Dorzolamide—glaucoma	1.32e-05	0.00028	CcSEcCtD
Bimatoprost—Insomnia—Pilocarpine—glaucoma	1.32e-05	0.00028	CcSEcCtD
Bimatoprost—Pain—Travoprost—glaucoma	1.31e-05	0.000279	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Brinzolamide—glaucoma	1.31e-05	0.000278	CcSEcCtD
Bimatoprost—Dyspnoea—Pilocarpine—glaucoma	1.3e-05	0.000276	CcSEcCtD
Bimatoprost—Pain—Brinzolamide—glaucoma	1.3e-05	0.000275	CcSEcCtD
Bimatoprost—Somnolence—Pilocarpine—glaucoma	1.3e-05	0.000275	CcSEcCtD
Bimatoprost—Depression—Timolol—glaucoma	1.29e-05	0.000275	CcSEcCtD
Bimatoprost—Angiopathy—Betaxolol—glaucoma	1.29e-05	0.000275	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—SMO—glaucoma	1.29e-05	0.000816	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Betaxolol—glaucoma	1.29e-05	0.000273	CcSEcCtD
Bimatoprost—Dyspepsia—Pilocarpine—glaucoma	1.28e-05	0.000272	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—EDN1—glaucoma	1.28e-05	0.000809	CbGpPWpGaD
Bimatoprost—Palpitations—Clonidine—glaucoma	1.26e-05	0.000267	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Pilocarpine—glaucoma	1.26e-05	0.000267	CcSEcCtD
Bimatoprost—Pain—Pilocarpine—glaucoma	1.25e-05	0.000264	CcSEcCtD
Bimatoprost—Cough—Clonidine—glaucoma	1.24e-05	0.000264	CcSEcCtD
Bimatoprost—Dizziness—Apraclonidine—glaucoma	1.24e-05	0.000264	CcSEcCtD
Bimatoprost—Erythema—Betaxolol—glaucoma	1.24e-05	0.000263	CcSEcCtD
Bimatoprost—Tension—Betaxolol—glaucoma	1.22e-05	0.000259	CcSEcCtD
Bimatoprost—Sinusitis—Timolol—glaucoma	1.22e-05	0.000258	CcSEcCtD
Bimatoprost—Chest pain—Clonidine—glaucoma	1.21e-05	0.000258	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—RPTOR—glaucoma	1.21e-05	0.000764	CbGpPWpGaD
Bimatoprost—Anxiety—Clonidine—glaucoma	1.21e-05	0.000257	CcSEcCtD
Bimatoprost—Asthenia—Acetazolamide—glaucoma	1.21e-05	0.000256	CcSEcCtD
Bimatoprost—Nervousness—Betaxolol—glaucoma	1.21e-05	0.000256	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	1.21e-05	0.000256	CcSEcCtD
Bimatoprost—Dry mouth—Clonidine—glaucoma	1.19e-05	0.000252	CcSEcCtD
Bimatoprost—Dermatitis—Apraclonidine—glaucoma	1.18e-05	0.000251	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—RPTOR—glaucoma	1.18e-05	0.000748	CbGpPWpGaD
Bimatoprost—Headache—Apraclonidine—glaucoma	1.18e-05	0.00025	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NCK2—glaucoma	1.17e-05	0.00074	CbGpPWpGaD
Bimatoprost—Vision blurred—Betaxolol—glaucoma	1.17e-05	0.000248	CcSEcCtD
Bimatoprost—Rhinitis—Timolol—glaucoma	1.17e-05	0.000248	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—EDN1—glaucoma	1.16e-05	0.000735	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TXN—glaucoma	1.16e-05	0.000734	CbGpPWpGaD
Bimatoprost—Asthenia—Brimonidine—glaucoma	1.16e-05	0.000246	CcSEcCtD
Bimatoprost—Infection—Clonidine—glaucoma	1.16e-05	0.000245	CcSEcCtD
Bimatoprost—Oedema peripheral—Timolol—glaucoma	1.15e-05	0.000244	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—NCK2—glaucoma	1.15e-05	0.000724	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Timolol—glaucoma	1.14e-05	0.000243	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—RPTOR—glaucoma	1.14e-05	0.000721	CbGpPWpGaD
Bimatoprost—Pruritus—Brimonidine—glaucoma	1.14e-05	0.000242	CcSEcCtD
Bimatoprost—Nervous system disorder—Clonidine—glaucoma	1.14e-05	0.000242	CcSEcCtD
Bimatoprost—Skin disorder—Clonidine—glaucoma	1.13e-05	0.00024	CcSEcCtD
Bimatoprost—Visual impairment—Timolol—glaucoma	1.12e-05	0.000238	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—C3—glaucoma	1.12e-05	0.000707	CbGpPWpGaD
Bimatoprost—Nausea—Apraclonidine—glaucoma	1.12e-05	0.000237	CcSEcCtD
Bimatoprost—Vertigo—Betaxolol—glaucoma	1.12e-05	0.000237	CcSEcCtD
Bimatoprost—Dizziness—Acetazolamide—glaucoma	1.11e-05	0.000236	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—NCK2—glaucoma	1.11e-05	0.000699	CbGpPWpGaD
Bimatoprost—Asthenia—Dorzolamide—glaucoma	1.11e-05	0.000235	CcSEcCtD
Bimatoprost—Asthenia—Travoprost—glaucoma	1.1e-05	0.000234	CcSEcCtD
Bimatoprost—Palpitations—Betaxolol—glaucoma	1.1e-05	0.000233	CcSEcCtD
Bimatoprost—Pruritus—Dorzolamide—glaucoma	1.09e-05	0.000232	CcSEcCtD
Bimatoprost—Eye disorder—Timolol—glaucoma	1.09e-05	0.000231	CcSEcCtD
Bimatoprost—Asthenia—Brinzolamide—glaucoma	1.09e-05	0.000231	CcSEcCtD
Bimatoprost—Pruritus—Travoprost—glaucoma	1.09e-05	0.000231	CcSEcCtD
Bimatoprost—Cough—Betaxolol—glaucoma	1.08e-05	0.00023	CcSEcCtD
Bimatoprost—Pruritus—Brinzolamide—glaucoma	1.07e-05	0.000228	CcSEcCtD
Bimatoprost—Dizziness—Brimonidine—glaucoma	1.07e-05	0.000227	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.06e-05	0.000669	CbGpPWpGaD
Bimatoprost—Angiopathy—Timolol—glaucoma	1.06e-05	0.000224	CcSEcCtD
Bimatoprost—Chest pain—Betaxolol—glaucoma	1.06e-05	0.000224	CcSEcCtD
Bimatoprost—Headache—Acetazolamide—glaucoma	1.05e-05	0.000224	CcSEcCtD
Bimatoprost—Anxiety—Betaxolol—glaucoma	1.05e-05	0.000224	CcSEcCtD
Bimatoprost—Insomnia—Clonidine—glaucoma	1.05e-05	0.000223	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.05e-05	0.000663	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Timolol—glaucoma	1.05e-05	0.000223	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	1.05e-05	0.000223	CcSEcCtD
Bimatoprost—Asthenia—Pilocarpine—glaucoma	1.05e-05	0.000222	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—SMO—glaucoma	1.04e-05	0.000658	CbGpPWpGaD
Bimatoprost—Dyspnoea—Clonidine—glaucoma	1.04e-05	0.00022	CcSEcCtD
Bimatoprost—Somnolence—Clonidine—glaucoma	1.03e-05	0.00022	CcSEcCtD
Bimatoprost—Dry mouth—Betaxolol—glaucoma	1.03e-05	0.000219	CcSEcCtD
Bimatoprost—Pruritus—Pilocarpine—glaucoma	1.03e-05	0.000219	CcSEcCtD
Bimatoprost—Dizziness—Dorzolamide—glaucoma	1.02e-05	0.000216	CcSEcCtD
Bimatoprost—Rash—Brimonidine—glaucoma	1.02e-05	0.000216	CcSEcCtD
Bimatoprost—Dermatitis—Brimonidine—glaucoma	1.02e-05	0.000216	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—C3—glaucoma	1.02e-05	0.000642	CbGpPWpGaD
Bimatoprost—Dizziness—Travoprost—glaucoma	1.02e-05	0.000216	CcSEcCtD
Bimatoprost—Erythema—Timolol—glaucoma	1.01e-05	0.000215	CcSEcCtD
Bimatoprost—Headache—Brimonidine—glaucoma	1.01e-05	0.000215	CcSEcCtD
Bimatoprost—Infection—Betaxolol—glaucoma	1.01e-05	0.000214	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Clonidine—glaucoma	1e-05	0.000213	CcSEcCtD
Bimatoprost—Dizziness—Brinzolamide—glaucoma	1e-05	0.000213	CcSEcCtD
Bimatoprost—Nausea—Acetazolamide—glaucoma	9.99e-06	0.000212	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—HDAC9—glaucoma	9.97e-06	0.000629	CbGpPWpGaD
Bimatoprost—Tension—Timolol—glaucoma	9.95e-06	0.000211	CcSEcCtD
Bimatoprost—Pain—Clonidine—glaucoma	9.95e-06	0.000211	CcSEcCtD
Bimatoprost—Nervous system disorder—Betaxolol—glaucoma	9.94e-06	0.000211	CcSEcCtD
Bimatoprost—Nervousness—Timolol—glaucoma	9.85e-06	0.000209	CcSEcCtD
Bimatoprost—Skin disorder—Betaxolol—glaucoma	9.84e-06	0.000209	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—HDAC9—glaucoma	9.76e-06	0.000616	CbGpPWpGaD
Bimatoprost—Rash—Dorzolamide—glaucoma	9.72e-06	0.000206	CcSEcCtD
Bimatoprost—Dermatitis—Dorzolamide—glaucoma	9.72e-06	0.000206	CcSEcCtD
Bimatoprost—Rash—Travoprost—glaucoma	9.68e-06	0.000205	CcSEcCtD
Bimatoprost—Dermatitis—Travoprost—glaucoma	9.67e-06	0.000205	CcSEcCtD
Bimatoprost—Headache—Dorzolamide—glaucoma	9.66e-06	0.000205	CcSEcCtD
Bimatoprost—Dizziness—Pilocarpine—glaucoma	9.64e-06	0.000205	CcSEcCtD
Bimatoprost—Headache—Travoprost—glaucoma	9.62e-06	0.000204	CcSEcCtD
Bimatoprost—Nausea—Brimonidine—glaucoma	9.59e-06	0.000204	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—EDN1—glaucoma	9.59e-06	0.000605	CbGpPWpGaD
Bimatoprost—Rash—Brinzolamide—glaucoma	9.56e-06	0.000203	CcSEcCtD
Bimatoprost—Vision blurred—Timolol—glaucoma	9.56e-06	0.000203	CcSEcCtD
Bimatoprost—Dermatitis—Brinzolamide—glaucoma	9.55e-06	0.000203	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NTRK2—glaucoma	9.54e-06	0.000602	CbGpPWpGaD
Bimatoprost—Headache—Brinzolamide—glaucoma	9.5e-06	0.000202	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—HDAC9—glaucoma	9.41e-06	0.000594	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—EDN1—glaucoma	9.38e-06	0.000592	CbGpPWpGaD
Bimatoprost—Rash—Pilocarpine—glaucoma	9.19e-06	0.000195	CcSEcCtD
Bimatoprost—Dermatitis—Pilocarpine—glaucoma	9.18e-06	0.000195	CcSEcCtD
Bimatoprost—Insomnia—Betaxolol—glaucoma	9.16e-06	0.000194	CcSEcCtD
Bimatoprost—Nausea—Dorzolamide—glaucoma	9.16e-06	0.000194	CcSEcCtD
Bimatoprost—Headache—Pilocarpine—glaucoma	9.13e-06	0.000194	CcSEcCtD
Bimatoprost—Nausea—Travoprost—glaucoma	9.12e-06	0.000194	CcSEcCtD
Bimatoprost—Vertigo—Timolol—glaucoma	9.11e-06	0.000193	CcSEcCtD
Bimatoprost—Dyspnoea—Betaxolol—glaucoma	9.03e-06	0.000192	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GSTT1—glaucoma	9.01e-06	0.000569	CbGpPWpGaD
Bimatoprost—Nausea—Brinzolamide—glaucoma	9.01e-06	0.000191	CcSEcCtD
Bimatoprost—Palpitations—Timolol—glaucoma	8.96e-06	0.00019	CcSEcCtD
Bimatoprost—Dyspepsia—Betaxolol—glaucoma	8.92e-06	0.000189	CcSEcCtD
Bimatoprost—Cough—Timolol—glaucoma	8.85e-06	0.000188	CcSEcCtD
Bimatoprost—Hypertension—Timolol—glaucoma	8.76e-06	0.000186	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betaxolol—glaucoma	8.75e-06	0.000186	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—EDN1—glaucoma	8.71e-06	0.000549	CbGpPWpGaD
Bimatoprost—Pain—Betaxolol—glaucoma	8.66e-06	0.000184	CcSEcCtD
Bimatoprost—Nausea—Pilocarpine—glaucoma	8.66e-06	0.000184	CcSEcCtD
Bimatoprost—Chest pain—Timolol—glaucoma	8.63e-06	0.000183	CcSEcCtD
Bimatoprost—Anxiety—Timolol—glaucoma	8.6e-06	0.000183	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	8.58e-06	0.000182	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—EDN1—glaucoma	8.52e-06	0.000538	CbGpPWpGaD
Bimatoprost—Dry mouth—Timolol—glaucoma	8.44e-06	0.000179	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—C3—glaucoma	8.38e-06	0.000529	CbGpPWpGaD
Bimatoprost—Asthenia—Clonidine—glaucoma	8.35e-06	0.000177	CcSEcCtD
Bimatoprost—Pruritus—Clonidine—glaucoma	8.23e-06	0.000175	CcSEcCtD
Bimatoprost—Infection—Timolol—glaucoma	8.22e-06	0.000175	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—C3—glaucoma	8.2e-06	0.000517	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NGFR—glaucoma	8.19e-06	0.000517	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Timolol—glaucoma	8.12e-06	0.000172	CcSEcCtD
Bimatoprost—Skin disorder—Timolol—glaucoma	8.04e-06	0.000171	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—SMO—glaucoma	7.8e-06	0.000492	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NTRK1—glaucoma	7.78e-06	0.000491	CbGpPWpGaD
Bimatoprost—Dizziness—Clonidine—glaucoma	7.7e-06	0.000163	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—SMO—glaucoma	7.64e-06	0.000482	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—C3—glaucoma	7.61e-06	0.00048	CbGpPWpGaD
Bimatoprost—Insomnia—Timolol—glaucoma	7.49e-06	0.000159	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—C3—glaucoma	7.44e-06	0.00047	CbGpPWpGaD
Bimatoprost—Dyspnoea—Timolol—glaucoma	7.38e-06	0.000157	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—SMO—glaucoma	7.37e-06	0.000465	CbGpPWpGaD
Bimatoprost—Somnolence—Timolol—glaucoma	7.36e-06	0.000156	CcSEcCtD
Bimatoprost—Rash—Clonidine—glaucoma	7.34e-06	0.000156	CcSEcCtD
Bimatoprost—Dermatitis—Clonidine—glaucoma	7.33e-06	0.000156	CcSEcCtD
Bimatoprost—Headache—Clonidine—glaucoma	7.29e-06	0.000155	CcSEcCtD
Bimatoprost—Dyspepsia—Timolol—glaucoma	7.29e-06	0.000155	CcSEcCtD
Bimatoprost—Asthenia—Betaxolol—glaucoma	7.27e-06	0.000154	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.27e-06	0.000459	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN2B—glaucoma	7.23e-06	0.000456	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1B1—glaucoma	7.18e-06	0.000453	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ABCA1—glaucoma	7.18e-06	0.000453	CbGpPWpGaD
Bimatoprost—Pruritus—Betaxolol—glaucoma	7.17e-06	0.000152	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CDKN2B—glaucoma	7.17e-06	0.000452	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Timolol—glaucoma	7.15e-06	0.000152	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NTRK2—glaucoma	7.13e-06	0.00045	CbGpPWpGaD
Bimatoprost—Pain—Timolol—glaucoma	7.08e-06	0.00015	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—NTRK2—glaucoma	6.98e-06	0.000441	CbGpPWpGaD
Bimatoprost—Nausea—Clonidine—glaucoma	6.91e-06	0.000147	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—EDN1—glaucoma	6.88e-06	0.000434	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NTRK2—glaucoma	6.74e-06	0.000425	CbGpPWpGaD
Bimatoprost—Dizziness—Betaxolol—glaucoma	6.7e-06	0.000142	CcSEcCtD
Bimatoprost—Rash—Betaxolol—glaucoma	6.39e-06	0.000136	CcSEcCtD
Bimatoprost—Dermatitis—Betaxolol—glaucoma	6.38e-06	0.000135	CcSEcCtD
Bimatoprost—Headache—Betaxolol—glaucoma	6.35e-06	0.000135	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NGF—glaucoma	6.32e-06	0.000399	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NGFR—glaucoma	6.12e-06	0.000386	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTHFR—glaucoma	6.06e-06	0.000382	CbGpPWpGaD
Bimatoprost—Nausea—Betaxolol—glaucoma	6.02e-06	0.000128	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—C3—glaucoma	6.01e-06	0.000379	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NGFR—glaucoma	5.99e-06	0.000378	CbGpPWpGaD
Bimatoprost—Asthenia—Timolol—glaucoma	5.94e-06	0.000126	CcSEcCtD
Bimatoprost—Pruritus—Timolol—glaucoma	5.86e-06	0.000124	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NTRK1—glaucoma	5.82e-06	0.000367	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NGFR—glaucoma	5.78e-06	0.000365	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTM1—glaucoma	5.74e-06	0.000362	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NTRK1—glaucoma	5.69e-06	0.000359	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—glaucoma	5.64e-06	0.000356	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—glaucoma	5.59e-06	0.000353	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CAV1—glaucoma	5.59e-06	0.000353	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CAV1—glaucoma	5.54e-06	0.00035	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NTRK1—glaucoma	5.49e-06	0.000347	CbGpPWpGaD
Bimatoprost—Dizziness—Timolol—glaucoma	5.47e-06	0.000116	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CDKN2B—glaucoma	5.36e-06	0.000338	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FN1—glaucoma	5.28e-06	0.000333	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BAD—glaucoma	5.26e-06	0.000332	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN2B—glaucoma	5.25e-06	0.000331	CbGpPWpGaD
Bimatoprost—Rash—Timolol—glaucoma	5.22e-06	0.000111	CcSEcCtD
Bimatoprost—Dermatitis—Timolol—glaucoma	5.21e-06	0.000111	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—BAD—glaucoma	5.21e-06	0.000329	CbGpPWpGaD
Bimatoprost—Headache—Timolol—glaucoma	5.19e-06	0.00011	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—EDN1—glaucoma	5.14e-06	0.000325	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—glaucoma	5.07e-06	0.00032	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN2B—glaucoma	5.06e-06	0.000319	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDN1—glaucoma	5.03e-06	0.000318	CbGpPWpGaD
Bimatoprost—Nausea—Timolol—glaucoma	4.92e-06	0.000104	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—EDN1—glaucoma	4.86e-06	0.000306	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NGF—glaucoma	4.73e-06	0.000298	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—glaucoma	4.72e-06	0.000298	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAV1—glaucoma	4.68e-06	0.000295	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NGF—glaucoma	4.63e-06	0.000292	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—C3—glaucoma	4.49e-06	0.000284	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NGF—glaucoma	4.46e-06	0.000282	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—C3—glaucoma	4.4e-06	0.000278	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—C3—glaucoma	4.24e-06	0.000268	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—glaucoma	4.23e-06	0.000267	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—glaucoma	4.19e-06	0.000264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—glaucoma	4.18e-06	0.000264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—glaucoma	4.14e-06	0.000262	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—glaucoma	4.09e-06	0.000258	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—glaucoma	4.06e-06	0.000256	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—glaucoma	3.95e-06	0.000249	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FN1—glaucoma	3.94e-06	0.000249	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—glaucoma	3.91e-06	0.000247	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BAD—glaucoma	3.9e-06	0.000246	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—glaucoma	3.86e-06	0.000244	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FN1—glaucoma	3.86e-06	0.000244	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BAD—glaucoma	3.82e-06	0.000241	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FN1—glaucoma	3.73e-06	0.000235	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BAD—glaucoma	3.68e-06	0.000232	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1B—glaucoma	3.66e-06	0.000231	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1B—glaucoma	3.63e-06	0.000229	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—glaucoma	3.54e-06	0.000223	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—glaucoma	3.36e-06	0.000212	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—glaucoma	3.24e-06	0.000204	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—glaucoma	3.13e-06	0.000198	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—glaucoma	3.07e-06	0.000194	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—glaucoma	3.02e-06	0.000191	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—glaucoma	2.96e-06	0.000187	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1B—glaucoma	2.71e-06	0.000171	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1B—glaucoma	2.66e-06	0.000168	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1B—glaucoma	2.56e-06	0.000162	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—glaucoma	2.51e-06	0.000159	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—glaucoma	2.46e-06	0.000155	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—glaucoma	2.37e-06	0.00015	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—glaucoma	2.28e-06	0.000144	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—glaucoma	2.26e-06	0.000142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—glaucoma	2.21e-06	0.000139	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—glaucoma	2.13e-06	0.000135	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—glaucoma	1.71e-06	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—glaucoma	1.67e-06	0.000105	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—glaucoma	1.61e-06	0.000102	CbGpPWpGaD
